ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Flexion Therapeutics Announces Appointment of Utpal Koppikar to its Board of Directors
July 13, 2021Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced the appointment of Utpal Koppikar, Chief Financial Officer of Atara Biotherapeutics, to its Board of Directors. Mr. Koppikar will serve as the chair of Flexion's audit committee. -
Flexion CEO says its Zilretta representatives will rev up the launch—and DTC ads will help, too
May 03, 2018Zilretta has several things going for it. It’s not an opioid painkiller—a plus at a time when opioid addiction is a nationwide issue. -
US FDA approves Flexion’s Zilretta to treat osteoarthritis knee pain
October 11, 2017The US Food and Drug Administration (FDA) has granted approval for specialist pharmaceutical firm Flexion Therapeutics’s Zilretta for the treatment of osteoarthritis (OA) knee pain.
Pharma Sources Insight January 2025
